Status: Recruiting
Local Antibiotics for Breast Implants
The BREAST-AB Trial is a multi-center, randomized, double blind, placebo-controlled trial investigating the efficacy of local application of gentamicin, vancomycin and cefazolin in decreasing all-cause implant explantation after breast reconstruction.
Participants needed: 1,003
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: Mikkel HerlyUpdated: Feb 12, 2026Locations: 8
Eligibility criteria
Age ≥ 18 years [+5]
Pregnancy [+7]